Patients with Depression or Anxiety Are Losing Sleep

Published Online: Saturday, April 1, 2006

According to an article reported in General Hospital Psychiatry (March-April 2005), patients with insomnia may be dealing with more than lost sleep. Chronic insomnia may in fact be a marker for a psychiatric disorder, particularly depression or anxiety. At least 40% of patients with chronic insomnia also have an underlying psychiatric disorder. Comorbid insomnia in patients with major depressive episodes often is manifested by difficulty in maintaining sleep. With generalized anxiety disorder, a patient's sleep is often shortened and fragmented. Unfortunately, the medications used to treat depression or anxiety actually may exacerbate the patient's inability to sleep soundly.

When insomnia and a psychiatric disorder coexist, it often is difficult to know which came first. Whereas a psychiatric disorder may cause insomnia, insomnia may be a factor in developing a psychiatric disorder. A history of insomnia is associated with a 4-fold increase in the risk of developing a new depressive disorder and a 2-fold increase in the risk of developing a new anxiety disorder. In fact, emerging data suggest that resolution of insomnia may improve psychiatric outcomes—underscoring the importance of a vigorous approach to treating insomnia. Because of the impact on insomnia of many medications for psychiatric conditions, an ideal approach would be a monotherapy that treats both insomnia and the psychiatric disorder.

Latest Articles
Patients with asthma can now access Spiriva Respimat with a prescription at pharmacies across the country.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Latest Issues